3186. Misbranding of sulfathiazole tablets.   U. S. v. Bowers' Pharmacy and
Cloyce A. Bowers. Pleas of nolo contendere. Fine of $100, plus costs,
against defendants jointly. (F. D. C. No. 29112. Sample Nos. 15894-K,
15896-K, 60615-K.)
INFORMATION FILED: April 28, 1950, Northern District of Indiana, against the
Bowers' Pharmacy, a partnership, Gary, Ind., and against Cloyce A. Bowers,
a partner in the partnership.
INTERSTATE SHIPMENT : From the State of Illinois into the State of Indiana,
of a quantity of sulfathiazole tablets.
ALLEGED VIOLATION : On or about May 13, 18, and 23, 1949, while the drug was
being held for sale after shipment in interstate commerce, the defendants
caused various quantities of the drug to be repackaged and sold without a
physician's prescription, which acts of the defendants resulted in the drug
being misbranded.
NATURE OF CHARGE: Misbranding, Sections 502 (b) (1) and (2), the re-
packaged tablets failed to bear the name and place of business of the manu-
facturer, packer, or distributor, and a statement of the quantity of the
contents; Section 502 (e) (1), a portion of the repackaged tablets failed to
bear a label containing the common or usual name of the drug; Section 502
(f) (1), the labeling of the repackaged tablets bore no directions for use;
and, Section 502 (f) (2), the labeling of the repackaged tablets bore no
warnings against use in those pathological conditions where their use may be
dangerous to health, and against unsafe dosage and methods and duration of
administration.
DISPOSITION: June 24, 1950. Pleas of nolo contendere having been entered,
the court imposed a fine of $100, plus costs, against the defendants jointly.